A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of Zemplar® Injection and Hectorol®
Injection on intestinal calcium absorption in Chronic Kidney Disease Stage 5 subjects on
hemodialysis.